| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/20/2006 | CN1276091C Feedback material-replenishing process of producing nisin |
| 09/20/2006 | CN1276090C Preparation of dairy ACE inhibitory peptide |
| 09/20/2006 | CN1276081C Recombinant human aFGF production method by gene engineering expression in silkworm body |
| 09/20/2006 | CN1275981C Method of monomerizing human serum albumin polymers |
| 09/20/2006 | CN1275980C Method of modifying microorganism-origin transglutaminase |
| 09/20/2006 | CN1275644C Medicinal composition its preparation method and its use in preparing medicine for treating SARS and its complication |
| 09/19/2006 | US7109319 For treatment of auto-immune and immunde disorders and chronic obstructive pulmonary disease; FAIL is an Fc receptor |
| 09/19/2006 | US7109309 Peptide fructose and protein conjugate with the same |
| 09/19/2006 | US7109308 Inhibiting tumor growth, inflammation, diabetic retinopathy, rheumatoid arthritis and psoriasis; diagnostic methods for detecting mutations in the VEGF2 coding sequence and alterations in the concentration of VEGF2 protein |
| 09/19/2006 | US7109304 Humanized anti-CD19 antibodies |
| 09/19/2006 | US7109301 Tenascin-C isoform as marker for neoplasias |
| 09/19/2006 | US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems |
| 09/19/2006 | US7109291 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody |
| 09/19/2006 | US7109041 Solubilzing and supporting G protein coupled receptors on beads and micelles for use in microtiter plates and cytometry; drug screening |
| 09/19/2006 | US7109017 Antibodies having preferential binding to proteases; screening for enzyme inhibitors used in therapy of neurodegenerative diseases, such as Alzheimer's disease |
| 09/19/2006 | US7109015 Capable of removing the N-terminal Met from bulky or acidic penultimate residues |
| 09/19/2006 | US7109012 Recombinant lysophosphatidic acid phosphatase |
| 09/19/2006 | US7109011 Nucleotide sequences coding polypeptide for use in the treatment of infections, pneumonia, toxic shock, brain and rheumatic diseases |
| 09/19/2006 | US7109009 Comprises nucleotide sequences coding enzymatic polypeptide for producing intermediates associated with thermoplastics, plasticizing agents, lubricants, hydraulic fluids, dyes, agricultural hemicals, pharmaceuticals and adhesives |
| 09/19/2006 | US7109008 L-glutamate oxidase |
| 09/19/2006 | US7109003 Methods for expressing and recovering human monoclonal antibodies to CTLA-4 |
| 09/19/2006 | US7109002 obtained by recombinant expression of DNA of human herpes virus type 8, and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma |
| 09/19/2006 | US7109001 COBRA gene and uses thereof |
| 09/19/2006 | US7109000 Isolated polypeptide of given sequence; use in diagnosis and treatment of cardiomyopathy, atherosclerosis, cancer and diabetes |
| 09/19/2006 | US7108999 Nucleotide sequences coding protein for use in treating eating disorder, autoimmune and viral diseases |
| 09/19/2006 | US7108991 Receptors whose endogenous ligand has not been identified (orphan) |
| 09/19/2006 | US7108989 Therapy |
| 09/19/2006 | US7108855 Characterized in that upon lysing the transformed host cells to isolate the recombinantly expressed protein a disulphide bond cleavage or reduction step is carried out with a disulphide bond cleavage agent |
| 09/19/2006 | US7108854 Also an antibody which specifically binds to the protein and a Hybridoma cell line that produces the protein; immunoprophylactic uses |
| 09/19/2006 | US7108853 Surface protein of Leptospira |
| 09/19/2006 | CA2235269C Monoclonal antibody br110 and uses thereof |
| 09/19/2006 | CA2083396C Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them |
| 09/14/2006 | WO2006096821A1 Microbial nanowires, related systems and methods of fabrication |
| 09/14/2006 | WO2006096515A2 Modified transferrin fusion proteins |
| 09/14/2006 | WO2006096451A2 Methionine sulfoxide antibodies |
| 09/14/2006 | WO2006096050A2 Glycoengineering in mushrooms |
| 09/14/2006 | WO2006096027A1 Manufactured product using and collagen solution manufacturing method and collagen separation method of animal tissue |
| 09/14/2006 | WO2006095474A1 Method for production of compound containing unnatural amino acid and/or hydroxy acid |
| 09/14/2006 | WO2005112976A3 Probiotic compounds from lactobacillus gg and uses therefor |
| 09/14/2006 | WO2005086875A3 A humanized anti-cea t84.66 antibody and uses thereof |
| 09/14/2006 | WO2005007121A3 Mutant interleukin-2(il-2) polypeptides |
| 09/14/2006 | WO2004108066A3 Neuronal regeneration and compound administration methods |
| 09/14/2006 | WO2004075836A3 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| 09/14/2006 | WO2004062619A3 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 09/14/2006 | WO2003095614A3 Cytokine polypeptides |
| 09/14/2006 | WO2003072759A3 Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers |
| 09/14/2006 | US20060206963 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 09/14/2006 | US20060206958 Transforming a plant or plant cell with a nucleotide sequence operably linked to a promoter active in plant cells encoding an NRC1 protein and forming a transgenic plant; family Solanaceae, genus Solanum; cells, seeds, fruits |
| 09/14/2006 | US20060206948 C-Reactive Protein (CRP); peptide biodrugs used to reduce body weight, adiposity, and alleviate insulin resistance and diabetes |
| 09/14/2006 | US20060206947 Heterodimeric protein binding compositions |
| 09/14/2006 | US20060205934 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 09/14/2006 | US20060205933 Pon polypeptides polynucleotides encoding same and compositions and methods utilizing same |
| 09/14/2006 | US20060205926 Human growth hormone domains |
| 09/14/2006 | US20060205925 Inhibits hemolysis by interacting with the plasma proteins clusterin; histidine rich glycoprotein (HRG); Streptococcal Inhibitor of Complement-mediated lysis |
| 09/14/2006 | US20060205924 Spliced variants of lgr6 |
| 09/14/2006 | US20060205668 For therapy of spinal cord injury or stroke, by overcoming the inhibitory effects of myelin on axonal regeneration |
| 09/14/2006 | US20060205660 OB protein-immunoglobulin chimeras |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205654 Screening methods for identifying disorders related to huXAG-1, huXAG-2 or huXAG-3 (colon cancer specific gene) activity |
| 09/14/2006 | US20060205653 protein that potentiates toxin activity of a Class A toxin complex protein against an insect; insecticides |
| 09/14/2006 | US20060205641 VANILREP4 polypeptides and VANILREP4 polynucleotides |
| 09/14/2006 | US20060205068 Useful in identifying and designing novel Bt toxin receptor ligands including novel insecticidal toxins; manipulating Bt toxin susceptibility in plant pests |
| 09/14/2006 | US20060205054 DNA encoding a Tumor Antigen Derived Gene-14 (TADG-14) protein which is overexpressed in ovarian, breast and colon carcinoma; for detecting and targeting of these carcinomas |
| 09/14/2006 | US20060205053 phosphatidyl-glycerolphosphate synthase; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase; for drug screening |
| 09/14/2006 | US20060205052 Bardet-Biedl susceptibility gene and uses thereof |
| 09/14/2006 | US20060205041 Recombinant bovine thrombin |
| 09/14/2006 | US20060205038 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 09/14/2006 | US20060205037 Modified transferrin fusion proteins |
| 09/14/2006 | US20060205036 Coagulation Factor VII polypeptides |
| 09/14/2006 | US20060205035 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents |
| 09/14/2006 | US20060205034 Expression vector comprising nucleotide sequences coding membrane protein for identifying modulators for prevention and treatment of lung, gastrointestinal and cell proliferative disorders |
| 09/14/2006 | US20060205033 Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 09/14/2006 | US20060205032 hSLIM modulates immune responses |
| 09/14/2006 | US20060205031 Newly identified cholinephosphotransferases and ethanolaminephosphotransferases |
| 09/14/2006 | US20060205030 Hydantoinase; carbamylases; nutraceuticals; animal feeds/husbandry |
| 09/14/2006 | US20060205021 Mammalian IAP gene family, primers, probes and detection methods |
| 09/14/2006 | US20060205020 Cell-cycle checkpoint genes |
| 09/14/2006 | US20060205016 Protein a based binding domains with desirable activities |
| 09/14/2006 | US20060204998 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 09/14/2006 | US20060204994 Novel human protein kinases and protein kinase-like enzymes |
| 09/14/2006 | US20060204962 Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy |
| 09/14/2006 | US20060204957 Mta1s, a steriod hormone receptor corepressor |
| 09/14/2006 | US20060204516 Compositions and methods for enhancing the immunogenicity of antigens |
| 09/14/2006 | US20060204512 Ephrin extracellular domain polypeptides for use in diagnosis prevention and treatment of cell proliferative disorders |
| 09/14/2006 | US20060204507 Method for generating an immune response and reagents therefor |
| 09/14/2006 | US20060204506 Anti-mesothelin antibodies |
| 09/14/2006 | US20060204503 Treatment of cancer using antibodies to polypeptides differentially expressed in human lung tumors |
| 09/14/2006 | US20060204498 Novel antagonists of cxcr3-binding cxc chemokines |
| 09/14/2006 | US20060204495 Isolation and identification of cross-reactive t cells |
| 09/14/2006 | US20060204494 Methionine sulfoxide antibodies |
| 09/14/2006 | US20060204493 Heteromultimeric molecules |
| 09/14/2006 | US20060204492 Compositions and methods for producing enhanced antibodies |
| 09/14/2006 | US20060204487 Production of high mannose proteins in plant culture |
| 09/14/2006 | CA2848698A1 Hydrolysis process for raw materials from the fishing and slaughterhouse industries and tanks for use therein |
| 09/14/2006 | CA2600391A1 Glycoengineering in mushrooms |
| 09/14/2006 | CA2599577A1 Nucleic acids and proteins and methods for making and using them |
| 09/13/2006 | EP1700918A2 Activatable recombinant neurotoxins |
| 09/13/2006 | EP1700916A1 Novel centromeric protein shugoshin |
| 09/13/2006 | EP1700868A2 A method for removing an antibody from blood or plasma |
| 09/13/2006 | EP1700867A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |